Sj
Hi! How can I help you?
Tsh is 11.63 on thronorm 100. Whats the next step
Reading File
Finding Sources
Reading File
The clinical picture here is clear. The patient is on Thronorm 100 mcg (levothyroxine 100 mcg/day) and has a TSH of 11.63 mIU/L — this is elevated (normal range ~0.5–4.5 mIU/L), meaning they are still hypothyroid/under-replaced.
Next Steps
1. Increase the Levothyroxine Dose
The goal of therapy is to normalize TSH. With a TSH of 11.63 on 100 mcg, the dose needs to be uptitrated.
- Increase by 25 mcg/day → go to Thronorm 125 mcg
- This is the standard incremental step in dose adjustment
"The dose can be increased by 25 µg/day every 6 weeks until the TSH is normalized." — Goodman & Gilman's Pharmacological Basis of Therapeutics
2. Recheck TSH in 6 Weeks
Follow-up TFTs (TSH ± free T4) should be done ~6 weeks after the dose change, because of levothyroxine's ~1-week plasma half-life and the time needed for the pituitary-thyroid axis to re-equilibrate.
3. Rule Out Causes of Under-replacement
Before simply increasing the dose, consider:
| Cause | Action |
|---|---|
| Poor compliance | Confirm the patient is taking it correctly (fasting, 30–60 min before food) |
| Malabsorption | Check for celiac disease, achlorhydria |
| Drug interactions | Calcium, iron, PPIs, cholestyramine — all reduce T4 absorption |
| Increased demand | Pregnancy (TSH targets are lower: <2.5 in 1st trimester) |
4. Target TSH
- Non-pregnant adults: TSH 0.5–4.0 mIU/L
- Elderly / cardiac disease: allow slightly higher target (0.5–6.0 mIU/L)
In summary: Increase to levothyroxine 125 mcg, recheck TSH in 6 weeks, and ensure correct administration technique.
Whats subclinical hypothroidism
Finding Sources
Reading File
Reading File
Subclinical Hypothyroidism
Definition
Elevated TSH with normal free T4 and free T3 — the patient has biochemical evidence of reduced thyroid reserve but no (or minimal) overt symptoms. It is a lab diagnosis, not a clinical one.
| Parameter | Subclinical Hypothyroidism | Overt Hypothyroidism |
|---|---|---|
| TSH | High (typically 4.5–10+) | High |
| Free T4 | Normal | Low |
| Symptoms | Absent or mild | Present |
Classification by TSH Level
- Mild / Grade I: TSH 4.5–10 mIU/L
- Severe / Grade II: TSH > 10 mIU/L ← your patient fits here
Prevalence
- ~8% in women, ~3% in men
- More common in whites and people >75 years old
- 4.3% prevalence in the general US population (NHANES III)
Natural History (Will it progress?)
Progression to overt hypothyroidism is not inevitable, but risk is higher with:
- TSH > 12 mIU/L → 77% cumulative progression over 10 years
- TSH 6–12 → 43% progression
- Positive TPO antibodies accelerate progression
- Women with elevated TSH + antithyroid antibodies progress at ~4.3%/year
Consequences if Untreated
- Lipid abnormalities: higher total cholesterol, LDL, apolipoprotein B → increased cardiovascular risk
- Mood: worse depressive symptoms, poorer response to antidepressants
- Cardiac: increased risk of myocardial infarction and atherosclerosis (especially TSH > 10)
- Pregnancy: associated with miscarriage, preterm birth, impaired fetal neurodevelopment
When to Treat
| Situation | Treat? |
|---|---|
| TSH > 10 mIU/L | Yes — strong indication |
| TSH 4.5–10 + symptoms | Yes |
| TSH 4.5–10, asymptomatic, young | Consider |
| TSH 4.5–10, elderly, asymptomatic | Often watch and wait |
| Pregnancy or planning pregnancy | Yes (lower TSH targets apply) |
"Levothyroxine is the drug of choice for patients with subclinical hypothyroidism and a serum TSH concentration above 10 mIU/L and for symptomatic patients." — Rosen's Emergency Medicine
Key Takeaway for Your Patient
Your patient (TSH 11.63 on levothyroxine 100 mcg) is not truly subclinical — they are inadequately treated overt/primary hypothyroidism where the free T4 is likely already low or borderline. Subclinical hypothyroidism typically refers to untreated or de novo elevated TSH with normal T4, not a patient already on replacement therapy.
This is a shared conversation. Sign in to Orris to start your own chat.